Abstract |
Human 3beta-hydroxysteroid dehydrogenase/ isomerase type 1 (3beta-HSD1) is a critical enzyme in the conversion of DHEA to estradiol in breast tumors and may be a target enzyme for inhibition in the treatment of breast cancer in postmenopausal women. Human 3beta-HSD2 participates in the production of cortisol and aldosterone in the human adrenal gland in this population. In our recombinant human breast tumor MCF-7 Tet-off cells that express either 3beta-HSD1 or 3beta-HSD2, trilostane and epostane inhibit the DHEA-induced proliferation of MCF-7 3beta-HSD1 cells with 12- to 16-fold lower IC(50) values compared to the MCF-7 3beta-HSD2 cells. The compounds also competitively inhibit purified human 3beta-HSD1 with 12- to 16-fold lower K(i) values compared to the noncompetitive K(i) values measured for human 3beta-HSD2. Using our structural model of 3beta-HSD1, trilostane or 17beta-acetoxy-trilostane was docked in the active site of 3beta-HSD1, and Arg195 in 3beta-HSD1 or Pro195 in 3beta-HSD2 was identified as a potentially critical residue (one of 23 non-identical residues in the two isoenzymes). The P195R mutant of 3beta-HSD2 were created, expressed and purified. Kinetic analyses of enzyme inhibition suggest that the high affinity, competitive inhibition of 3beta-HSD1 by trilostane and epostane may be related to the presence of Arg195 in 3beta-HSD1 vs. Pro195 in 3beta-HSD2.
|
Authors | James L Thomas, Kevin M Bucholtz, Jingping Sun, Vance L Mack, Balint Kacsoh |
Journal | Molecular and cellular endocrinology
(Mol Cell Endocrinol)
Vol. 301
Issue 1-2
Pg. 174-82
(Mar 25 2009)
ISSN: 0303-7207 [Print] Ireland |
PMID | 18955108
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- Aromatase Inhibitors
- Coenzymes
- Enzyme Inhibitors
- Mutant Proteins
- RNA, Messenger
- Dihydrotestosterone
- Estrone
- Dehydroepiandrosterone
- Estradiol
- Arginine
- 3-Hydroxysteroid Dehydrogenases
- trilostane
|
Topics |
- 3-Hydroxysteroid Dehydrogenases
(antagonists & inhibitors, chemistry)
- Arginine
(metabolism)
- Aromatase Inhibitors
(pharmacology)
- Blotting, Western
- Breast Neoplasms
(enzymology, genetics)
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Coenzymes
(metabolism)
- Dehydroepiandrosterone
(pharmacology)
- Dihydrotestosterone
(analogs & derivatives, pharmacology)
- Enzyme Inhibitors
(pharmacology)
- Estradiol
(pharmacology)
- Estrone
(pharmacology)
- Female
- Gene Expression Regulation, Enzymologic
(drug effects)
- Gene Expression Regulation, Neoplastic
(drug effects)
- Humans
- Kinetics
- Mutant Proteins
(metabolism)
- RNA, Messenger
(genetics, metabolism)
- Reverse Transcriptase Polymerase Chain Reaction
- Substrate Specificity
(drug effects)
|